Search results for

A new animated comedy series, Hopeless Pictures centers on a dysfunctional Hollywood indie film studio. Actor Bob Balaban writes, directs and produces the show, which will debut on the Independent Film Channel August 19.

Our founding myth suggests the Americas were a lightly populated wilderness before Europeans arrived. Historian Charles C. Mann compiled evidence of a far more complex and populous pre-Columbian society. He tells John Ydstie about 1491.

Confrontations erupt as Israeli settlers protest their forced removal from the Gaza Strip. The clashes came as other settlers rushed to leave the area before the midnight withdrawal deadline. At least 50 arrests have been reported.

Atlanta is on the verge of criminalizing panhandling in certain parts of the city. For the rest of the country, though, the question still remains: to give or not to give.

Lance Cpl. Brett Wightman was one of 14 Marines killed in an Aug. 3 roadside bombing in northern Iraq. The 22-year-old Marine reservist's death touched many people in his hometown of Sabina, Ohio.

A new survey finds significant differences of opinion on immigration policy among U.S.-born Latinos and those born abroad. Nearly half of all Mexicans would move to the U.S. if they could, it says.

President Bush is on his way home from a four-country tour of Asia. His last stop was in Mongolia, where he expressed thanks for that country's contribution to the Iraq war effort. He also praised Mongolia's movement toward democracy and a more open economy.

David Cole, chairman of the Center for Automotive Research in Ann Arbor, Mich., discusses General Motors' recent troubles.

Reporter Trish Anderton recently visited Ohio for a rally of owners of Amphicars -- a vehicle that's a combination car and boat, produced in Germany from 1961 to 1968. Owners around America cherish the few that survive.

The first federal trial over the painkiller Vioxx begins Tuesday in Houston. Pharmaceutical company Merck has defended its handling of the drug in two previous state cases, losing one of them. Merck withdrew Vioxx from the market last year after a study showed that the drug posed heart risks.